U.S. Government To Purchase Eli Lilly COVID-19 Antibody Drug Pending FDA Approval
The U.S. government has agreed to purchase 300,000 doses of Eli Lilly's COVID-19 antibody treatment. It plans to pay $375 million for the vials of the drug.
The U.S. government has agreed to purchase 300,000 doses of Eli Lilly's COVID-19 antibody treatment. It plans to pay $375 million for the vials of the drug.